WOMAC standardized questionnaires were used to evaluate joint discomfort. Lower score indicates better joint health. UC-II® significantly improved joint function, mobility and flexibility compared to placebo and glucosamine + chondroitin using three different assessment tools: WOMAC, VAS and Lequesne functional index.
33% Reduction in WOMAC Score
40% Reduction in VAS Score
20% Reduction in LFI Score
References
*Lugo JP, et al. Nutr J. 2016;15:14.
1. Vasiliadis HS, Tsikopoulos K. Glucosamine and chondroitin for the treatment of osteoarthritis. World J Orthop. 2017;8(1):1-11. Published 2017 Jan 18. doi:10.5312/wjo.v8.i1.1
2. Henrotin Y, Chevalier X, Herrero-Beaumont G, et al. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities. BMC Res Notes. 2013;6:115. Published 2013 Mar 26. doi:10.1186/1756-0500-6-115